- Home
- SBAC vs BNTX Comparison
SBAC vs BNTX Comparison
Compare SBAC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBAC
- BNTX
- Stock Information
- Founded
- SBAC 1989
- BNTX 2008
- Country
- SBAC United States
- BNTX Germany
- Employees
- SBAC N/A
- BNTX N/A
- Industry
- SBAC Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBAC Real Estate
- BNTX Health Care
- Exchange
- SBAC Nasdaq
- BNTX Nasdaq
- Market Cap
- SBAC 20.2B
- BNTX 26.4B
- IPO Year
- SBAC 1999
- BNTX 2019
- Fundamental
- Price
- SBAC $199.63
- BNTX $105.47
- Analyst Decision
- SBAC Buy
- BNTX Strong Buy
- Analyst Count
- SBAC 15
- BNTX 14
- Target Price
- SBAC $244.13
- BNTX $139.06
- AVG Volume (30 Days)
- SBAC 983.3K
- BNTX 656.5K
- Earning Date
- SBAC 11-03-2025
- BNTX 11-03-2025
- Dividend Yield
- SBAC 2.25%
- BNTX N/A
- EPS Growth
- SBAC 71.76
- BNTX N/A
- EPS
- SBAC 8.15
- BNTX N/A
- Revenue
- SBAC $2,724,524,000.00
- BNTX $3,380,387,551.00
- Revenue This Year
- SBAC $6.88
- BNTX N/A
- Revenue Next Year
- SBAC $2.72
- BNTX $13.00
- P/E Ratio
- SBAC $24.26
- BNTX N/A
- Revenue Growth
- SBAC 1.82
- BNTX 6.98
- 52 Week Low
- SBAC $185.45
- BNTX $81.20
- 52 Week High
- SBAC $248.62
- BNTX $129.27
- Technical
- Relative Strength Index (RSI)
- SBAC 56.63
- BNTX 55.01
- Support Level
- SBAC $192.69
- BNTX $103.10
- Resistance Level
- SBAC $199.49
- BNTX $108.05
- Average True Range (ATR)
- SBAC 3.55
- BNTX 2.95
- MACD
- SBAC 1.94
- BNTX 0.46
- Stochastic Oscillator
- SBAC 97.91
- BNTX 51.14
About SBAC SBA Communications Corporation
SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.